Quantcast

Global Specialty Generics Market 2019-2024: Anticipating Growth at a Rate of 11.9%, Aided by the Patent Expiration of a Number of Branded Specialty Drugs – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Specialty
Generics Market: Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2019-2024”
report has been added to ResearchAndMarkets.com’s
offering.

The global specialty generics market reached a value of US$ 44.8 Billion
in 2018. Looking forward, the market value is further expected to reach
US$ 88.9 Billion by 2024, exhibiting a CAGR of 11.9% during 2019-2024.

Compared to traditional generics, the speciality generics market is more
concentrated with fewer players due to their complex manufacturing
requirements, higher capital costs and relatively lower volumes as a
result of smaller patient population. This results in lower price
reduction compared to the branded drug and consequently higher margins
compared to traditional generics. Speciality generics require special
handling, administration, monitoring and generally need prior
authorization to order them.

The global speciality generics market is currently being driven by
several factors such as rising ageing population, patent expiration of a
number of branded specialty drugs, increasing prevalence of various
life-threatening diseases such as cancer, multiple sclerosis, HIV, etc.,
cost containment measures from healthcare providers, growth from
emerging markets, etc.

This latest report provides a deep insight into the global specialty
generics market covering all its essential aspects. This ranges from
macro overview of the market to micro details of the industry
performance, recent trends, key market drivers and challenges, SWOT
analysis, Porter’s five forces analysis, value chain analysis, etc. This
report is a must-read for entrepreneurs, investors, researchers,
consultants, business strategists, and all those who have any kind of
stake or are planning to foray into the global smart lighting market in
any manner.

Key Questions Answered

  • How has the global specialty generics market performed so far and how
    will it perform in the coming years?
  • What are the key regional markets in the global specialty generics
    industry?
  • What is the breakup of the global specialty generics market based on
    the indication?
  • What is the breakup of the global specialty generics market based on
    the route of administration?
  • What is the breakup of the global specialty generics market based on
    the distribution channel?
  • \What are the various stages in the value chain of the global
    specialty generics industry?
  • What are the key driving factors and challenges in the global
    specialty generics market?
  • What is the structure of the global specialty generics industry and
    who are the key players?
  • What is the degree of competition in the global specialty generics
    market?

Key Topics Covered

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market

6.1 Market Overview

6.2 Market Performance

6.3 Market Breakup by Route of Administration

6.4 Market Breakup by Indication

6.5 Market Breakup by Distribution Channel

6.6 Market Breakup by Region

6.7 Market Forecast

6.8 SWOT Analysis

6.9 Value Chain Analysis

6.10 Porters Five Forces Analysis

6.11 Key Market Drivers and Success Factors

7 Market Breakup by Route of Administration

7.1 Injectable

7.2 Oral

7.3 Others

8 Market Breakup by Indication

8.1 Oncology

8.2 Autoimmune Diseases

8.3 Infectious Diseases

8.4 Others

9 Market Breakup by Distribution Channel

9.1 Retail Pharmacies

9.2 Specialty Pharmacies

9.3 Hospital Pharmacies

10 Market Breakup by Region

10.1 North America

10.2 Europe

10.3 Asia Pacific

10.4 Latin America

10.5 Middle East and Africa

11 Competitive Landscape

11.1 Market Structure

11.2 Key Players

11.3 Profiles of Key Players

11.3.1 Teva Pharmaceuticals Industries

11.3.2 Akorn Inc.

11.3.3 Mylan N.V.

11.3.4 Mallinckrodt

11.3.5 Sandoz International GmbH

11.3.6 Pfizer Inc.

11.3.7 Sun Pharmaceutical Industries Ltd.

11.3.8 Valeant Pharmaceuticals

11.3.9 Apotex Corp.

11.3.10 Endo International PLC

For more information about this report visit https://www.researchandmarkets.com/r/kp9y17

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Generic
Drugs

Read the full article

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.